image description

Tag: Xolair

Existing Asthma Medication Shows Effectiveness for Lupus

January 14, 2019 A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus activity by reducing production of type 1 interferons.  The study involved 15 patients with lupus who had elevated amounts of an antibody immunoglobulin E and a minimum level of disease […] Read More
Stay informed about events, research developments, and ways you can help. Sign up for updates